Communication Bridge-2 randomized controlled trial: Recruitment and baseline features.

ABSTRACT:

Introduction

Non-pharmacological interventions may offer significant benefits to the quality of life for persons with primary progressive aphasia (PPA) and their care partners but have lacked efficacy trials. To help fill the efficacy gap, we provide the feasibility of recruitment, enrollment, randomization, and baseline data for the Communication Bridge-2 (CB2) randomized controlled trial (RCT).

Methods

CB2 is the first international, single enrollment site, Phase 2, Stage 2, parallel-group, active control, RCT delivered via video chat to individuals with PPA and their care partners. Participants were recruited, screened, and randomized into one of two speech-language intervention arms.

Results

Ninety-five participant dyads (PPA mean baseline age: 67.1; 48% female) f

SUBMITTER: Rogalski E 

PROVIDER: S-EPMC11771146 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature